Regional data analysis ofCandidanon-albicansstrains collected in United States medical sites over a 6-year period, 2006-2011
出版年份 2014 全文链接
标题
Regional data analysis ofCandidanon-albicansstrains collected in United States medical sites over a 6-year period, 2006-2011
作者
关键词
-
出版物
MYCOSES
Volume 57, Issue 10, Pages 602-611
出版商
Wiley
发表日期
2014-05-26
DOI
10.1111/myc.12206
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Interlaboratory Variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST Methods: Should the Clinical Laboratory Be Testing This Agent?
- (2013) A. Espinel-Ingroff et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Multicenter Study of Anidulafungin and Micafungin MIC Distributions and Epidemiological Cutoff Values for Eight Candida Species and the CLSI M27-A3 Broth Microdilution Method
- (2013) M. A. Pfaller et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Editorial Commentary: Candida glabrata and FKS Mutations: Witnessing the Emergence of the True Multidrug-Resistant Candida
- (2013) L. Ostrosky-Zeichner CLINICAL INFECTIOUS DISEASES
- Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations
- (2013) Barbara D. Alexander et al. CLINICAL INFECTIOUS DISEASES
- Epidemiological changes with potential implication for antifungal prescription recommendations for fungaemia: data from a nationwide fungaemia surveillance programme
- (2013) M.C. Arendrup et al. CLINICAL MICROBIOLOGY AND INFECTION
- Echinocandin and Triazole Antifungal Susceptibility Profiles for Clinical Opportunistic Yeast and Mold Isolates Collected from 2010 to 2011: Application of New CLSI Clinical Breakpoints and Epidemiological Cutoff Values for Characterization of Geographic and Temporal Trends of Antifungal Resistance
- (2013) M. A. Pfaller et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Impact of an Antimicrobial Stewardship Program Comprehensive Care Bundle on Management of Candidemia
- (2013) Allen Antworth et al. PHARMACOTHERAPY
- DifferentialIn VivoActivities of Anidulafungin, Caspofungin, and Micafungin against Candida glabrata Isolates with and withoutFKSResistance Mutations
- (2012) Maiken Cavling Arendrup et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Changes in Incidence and Antifungal Drug Resistance in Candidemia: Results From Population-Based Laboratory Surveillance in Atlanta and Baltimore, 2008-2011
- (2012) A. A. Cleveland et al. CLINICAL INFECTIOUS DISEASES
- EUCAST technical note on the EUCAST definitive document EDef 7.2: method for the determination of broth dilution minimum inhibitory concentrations of antifungal agents for yeasts EDef 7.2 (EUCAST-AFST)*
- (2012) Maiken C. Arendrup et al. CLINICAL MICROBIOLOGY AND INFECTION
- The PATH (Prospective Antifungal Therapy) Alliance® registry and invasive fungal infections: update 2012
- (2012) Nkechi Azie et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- The changing epidemiology of healthcare-associated candidemia over three decades
- (2012) Daniel Diekema et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Epidemiology and outcomes of candidemia in 3648 patients: data from the Prospective Antifungal Therapy (PATH Alliance®) registry, 2004–2008
- (2012) Michael Pfaller et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Frequency of Decreased Susceptibility and Resistance to Echinocandins among Fluconazole-Resistant Bloodstream Isolates of Candida glabrata
- (2012) M. A. Pfaller et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Assessment of Accuracy of Identification of Pathogenic Yeasts in Microbiology Laboratories in the United Kingdom
- (2012) A. M. Borman et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Candida guilliermondii and Other Species of Candida Misidentified as Candida famata: Assessment by Vitek 2, DNA Sequencing Analysis, and Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry in Two Global Antifungal Surveillance Programs
- (2012) Mariana Castanheira et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Progress in Antifungal Susceptibility Testing of Candida spp. by Use of Clinical and Laboratory Standards Institute Broth Microdilution Methods, 2010 to 2012
- (2012) M. A. Pfaller et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Significance of Molecular Identification and Antifungal Susceptibility of Clinically Significant Yeasts and Moulds in a Global Antifungal Surveillance Programme
- (2012) Michael A. Pfaller et al. MYCOPATHOLOGIA
- Hidden Killers: Human Fungal Infections
- (2012) G. D. Brown et al. Science Translational Medicine
- Antifungal Drug Resistance: Mechanisms, Epidemiology, and Consequences for Treatment
- (2011) Michael A. Pfaller AMERICAN JOURNAL OF MEDICINE
- Comparative Effects of Micafungin, Caspofungin, and Anidulafungin against a Difficult-To-Treat Fungal Opportunistic Pathogen, Candida glabrata
- (2011) Elisabetta Spreghini et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria
- (2011) Michael A. Pfaller et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Low Prevalence of fks1 Hot Spot 1 Mutations in a Worldwide Collection of Candida Strains
- (2010) M. Castanheira et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Epidemiology of Invasive Mycoses in North America
- (2010) Michael A. Pfaller et al. CRITICAL REVIEWS IN MICROBIOLOGY
- Geographic variation in the frequency of isolation and fluconazole and voriconazole susceptibilities of Candida glabrata: an assessment from the ARTEMIS DISK Global Antifungal Surveillance Program
- (2010) Michael A. Pfaller et al. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
- Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-Year Analysis of Susceptibilities of Candida Species to Fluconazole and Voriconazole as Determined by CLSI Standardized Disk Diffusion
- (2010) M. A. Pfaller et al. JOURNAL OF CLINICAL MICROBIOLOGY
- Mortality, length of hospitalization, and costs associated with invasive fungal infections in high-risk patients
- (2009) J. Menzin et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001-2007)
- (2009) Nikolaos V. Sipsas et al. CANCER
- Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America
- (2009) Peter G. Pappas et al. CLINICAL INFECTIOUS DISEASES
- International Study of the Prevalence and Outcomes of Infection in Intensive Care Units
- (2009) Jean-Louis Vincent JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Variation in Susceptibility of Bloodstream Isolates of Candida glabrata to Fluconazole According to Patient Age and Geographic Location in the United States in 2001 to 2007
- (2009) M. A. Pfaller et al. JOURNAL OF CLINICAL MICROBIOLOGY
- The evolution of resistantCandida species in cancer centers
- (2008) James Riddell et al. CANCER
- The changing epidemiology of invasive candidiasis
- (2008) Ray Hachem et al. CANCER
- Candida parapsilosis, an Emerging Fungal Pathogen
- (2008) D. Trofa et al. CLINICAL MICROBIOLOGY REVIEWS
- Secular Trends in Candidemia-Related Hospitalization in the United States, 2000–2005
- (2008) Marya D. Zilberberg et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Increasing incidence of Candida parapsilosis candidemia with caspofungin usage
- (2007) Graeme N. Forrest et al. JOURNAL OF INFECTION
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started